Active Pharmaceutical Ingredients - Dr Reddy's
Active Pharmaceutical Ingredients - Dr Reddy's

About Dapagliflozin (Amorphous) API

Product
  • Therapeutic Category Anti-Diabético

  • CAS Number

    461432-26-8

  • API Technology

    Synthetic

  • Dose Form

    Oral Solids

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, Brazil DMF, EUDMF, Canada DMF, Korea DMF, Russia DMF

Mecanismo de Ação

Sodium-glucose cotransporter 2 (SGLT2), expressed in the proximal renal tubules, is responsible for the majority of the reabsorption of filtered glucose from the tubular lumen. Dapagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, dapagliflozin reduces reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion

Indicação

FARXIGA is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Especialização do Dr. Reddy

Com sede em Hyderabad, Índia, o Dr. Reddy's Laboratories é um dos principais fornecedores de Ingredientes Farmacêuticos Ativos (API) do mundo. O negócio de API do Dr. Reddy é um parceiro preferencial para empresas farmacêuticas nos EUA, Europa, Brasil, América Latina, Japão, China, Coréia e mercados emergentes.

Os negócios de API do Dr. Reddy prosperam com os profundos pontos fortes técnicos estabelecidos nos últimos 30 anos no desenvolvimento e fabricação de APIs complexas, como esteróides, peptídeos, moléculas complexas de cadeia longa e APIs altamente potentes (HPAPIs / medicamentos para oncologia). Essa experiência é complementada por nossa capacidade em propriedade intelectual e assuntos regulatórios, o que nos ajuda a cumprir e exceder consistentemente os padrões regulatórios. A API do Dr. Reddy Dapagliflozina (amorfa) é o resultado de uma extensa experiência em pesquisa e desenvolvimento, PI e regulamentação.

Um componente essencial para ajudar nossos clientes a serem os primeiros no mercado é uma cadeia de suprimentos responsiva. Conseguimos isso garantindo que todas as nossas instalações estejam operando com eficiência e com os mais recentes padrões de qualidade, segurança e produtividade. Uma forte interconexão entre negócios e fábricas permite uma reação rápida às mudanças dinâmicas do mercado, para que possamos evitar escassez e atender a súbitas oscilações na demanda.

 

Dr. Reddy's is a leading Dapagliflozin manufacturer offering a reliable and cost-effective solution for your SGLT2 inhibitor medication needs. Our dapagliflozin API is manufactured to meet the highest quality standards Contact us today to request a quote for bulk dapagliflozin price and discuss your specific requirements.

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Country *
Select Product *
Select Regulatory Requirements
Select Purpose

Related APIs

Liraglutida

Anti-Diabético

arrow

Glimepirida

Anti-Diabético

arrow

Cloridrato De Pioglitazona

Anti-Diabético

arrow

Linagliptina

Anti-Diabético

arrow

Cloridrato De Sitagliptina

Anti-Diabético

arrow

Dapagliflozina (amorfa)

Anti-Diabético

arrow

Semaglutide

Anti-Diabético

arrow

FAQs

What is Dapagliflozin Amorphous API used for?
  • Dapagliflozin Amorphous API is used to treat type 2 diabetes, chronic kidney disease, and heart failure.

What are the benefits of Dapagliflozin Amorphous API?
  • Lowers blood glucose, promotes weight loss, reduces blood pressure, and decreases cardiovascular risks.

What is the safety guide for Dapagliflozin Amorphous API?
  • Handle with care, avoid inhalation, ingestion, and contact with eyes and skin. Use protective equipment.

Aviso legal

No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.